1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant M-VAC
    Meeting Abstract

    Sarkis, A.; Bajorin, D.; Netto, G.; Schultz, P.; Zhang, Z. F.; Cordon-Cardo, C.; Scher, H.; Reuter, V. E.
    Modern Pathology (1994)

    Fulltext@MSK | Save
  • A truncated cyclin D1 transcript is overexpressed in a human breast cancer cell line bearing an altered D1 gene
    Meeting Abstract

    Lebwohl, D. E.; Muise-Helmericks, R.; Sepp-Lorenzino, L.; Serve, S.; Borgen, P.; Rosen, N.
    Journal of Cellular Biochemistry (1994)

    Fulltext@MSK | Save
  • Herbimycin A inhibits the IGF-I receptor protein tyrosine kinase and cellular proliferation in human breast cancer cells
    Meeting Abstract

    Sepp-Lorenzino, L.; Ma, Z. P.; Rosen, N.; Lebwohl, D. E.
    Journal of Cellular Biochemistry (1994)

    Fulltext@MSK | Save
  • Treatment of advanced ovarian cancer (AOC) with high-dose (HD) carboplatin (C) and escalating-dose taxol (TXL) with cyclophosphamide (CTX)/TXL-primed peripheral blood progenitor cells (PBP) as hematological support (HS): A phase I study
    Meeting Abstract

    Fennelly, D.; Schneider, J.; Hakes, T.; Crown, J.; Bengala, C.; Reich, L.; Moore, M.; Gulati, S.; Shapiro, F.; Barakat, R.; more...
    Gynecologic Oncology (1994)

    Fulltext@MSK | Save
  • Immunization of melanoma patients against G(D3) ganglioside with BEC2, an anti-idiotypic monoclonal antibody
    Meeting Abstract

    Chapman, P. B.; Houghton, A. N.
    Cancer Biotherapy (1994)

    Fulltext@MSK | Save
  • Protein kinase Cβ1 (PKCβ1) expression and localization: Critical events in gastric cancer cell invasion?
    Meeting Abstract

    Schwartz, G. K.; Kiley, S. C.; Dhupar, S. K.; Kelsen, D.; Albino, A.
    Clinical and Experimental Metastasis (1994)

    Fulltext@MSK | Save
  • Efficacy of prolonged paclitaxel (P) infusion after failure of prior short taxane infusion: A phase II and pharmacologic study in metastatic breast cancer (MBC)
    Meeting Abstract

    Hochhauser, D.; Seidman, A. D.; Gollub, M.; Edelman, B.; Hudis, C.; Francis, P.; Auguste, L.; Bellettieri, R.; Currie, V.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save
  • Ongoing phase II study of intravenous recombinant human anti-p185 HER2 monoclonal antibody 4D5 (MAb 4D5) in patients with stage IV breast cancer overexpressing HER2
    Meeting Abstract

    Baselga, J.; Tripathy, D.; Mendelsohn, J.; Benz, C.; Rosen, P. P.; Henderson, I. C.; Twaddell, T.; Norton, L.
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save
  • Phase I trial of sequential edatrexate (ETX) followed by paclitaxel (PTX) in patients with advanced breast cancer: A design based on in-vitro (IV) synergy
    Meeting Abstract

    Fennelly, D.; Hudis, C.; Seidman, A.; Hamilton, N.; Raptis, G.; Baselga, J.; Sklarin, N.; Norton, L.
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save
  • Results of sequential dose-intensive adjuvant therapy with doxorubicin and cyclophosphamide
    Meeting Abstract

    Hudis, C.; Lebwohl, D.; Yao, T. J.; Crown, J.; Gilewski, T.; Currie, V.; Raptis, G.; Seidman, A.; Fennelly, D.; Kesselman, E.; more...
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save